AR012438A1 - Preparacion liquida antiacida libre de conservadores que es de ph estable, durante su vida de almacenamiento - Google Patents
Preparacion liquida antiacida libre de conservadores que es de ph estable, durante su vida de almacenamientoInfo
- Publication number
- AR012438A1 AR012438A1 ARP980101735A ARP980101735A AR012438A1 AR 012438 A1 AR012438 A1 AR 012438A1 AR P980101735 A ARP980101735 A AR P980101735A AR P980101735 A ARP980101735 A AR P980101735A AR 012438 A1 AR012438 A1 AR 012438A1
- Authority
- AR
- Argentina
- Prior art keywords
- stable
- during
- conservative
- liquid preparation
- approximately
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Preparacion líquida antiácida libre de conservadores para uso gastrointestinal, que mantiene su pH estable durante su vida de almacenamiento,posee resistencia superior frente al ataque microbiano y propiedades mejoradas de sabor, lacu al comprende: a) aproximadamente 2% a aproximadamente 40% p/v decarbonato de calcio; b) una cantidad de uno o más agentes ajustadores de pH capaces de mantener la preparacion antiácida a un pH mayor de aprosimadamente9.0; y c) opcionalmente,uno o más de otros excipientes farmacéuticamente aceptables, en un vehículo acuos; en donde el pH de la preparacion líquidaantiácida es mayor de aproximadamente 9.0.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/838,239 US5914135A (en) | 1997-04-16 | 1997-04-16 | Liquid antacid compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012438A1 true AR012438A1 (es) | 2000-10-18 |
Family
ID=25276618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101735A AR012438A1 (es) | 1997-04-16 | 1998-04-15 | Preparacion liquida antiacida libre de conservadores que es de ph estable, durante su vida de almacenamiento |
Country Status (18)
Country | Link |
---|---|
US (1) | US5914135A (es) |
EP (1) | EP0872241B1 (es) |
JP (1) | JPH10316577A (es) |
KR (1) | KR100588245B1 (es) |
CN (1) | CN1174754C (es) |
AR (1) | AR012438A1 (es) |
AT (1) | ATE232105T1 (es) |
AU (1) | AU727008B2 (es) |
BR (1) | BR9801044B1 (es) |
CZ (1) | CZ292399B6 (es) |
DE (1) | DE69811137T2 (es) |
DK (1) | DK0872241T3 (es) |
ES (1) | ES2191254T3 (es) |
HU (1) | HU224195B1 (es) |
NZ (1) | NZ330173A (es) |
PL (1) | PL189771B1 (es) |
RU (1) | RU2193889C2 (es) |
ZA (1) | ZA983167B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9226905D0 (en) * | 1992-12-24 | 1993-02-17 | Wellcome Found | Pharmaceutical preparation |
US6048552A (en) * | 1997-03-26 | 2000-04-11 | Chattem Chemicals, Inc. | DASC compositions, process for preparing same and suspensions containing same |
US5914135A (en) * | 1997-04-16 | 1999-06-22 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
AU4759099A (en) * | 1998-09-21 | 2000-03-23 | Mcneil-Ppc, Inc. | Heat stable antacid and antigas suspensions |
AU2004201831B2 (en) * | 1998-09-21 | 2006-11-02 | Mcneil-Ppc, Inc. | Heat stable antacid and antigas suspensions |
US6887926B1 (en) | 2001-11-16 | 2005-05-03 | Oatey Co. | Bonding compositions for chlorinated polymers and methods of using the same |
US7198653B2 (en) | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
EP1937362B1 (en) | 2005-09-16 | 2013-03-27 | Selamine Ltd. | Bisphosphonate formulation |
US7473684B2 (en) * | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
US9138414B1 (en) | 2006-09-15 | 2015-09-22 | Delavau Llc | Calcium supplement having enhanced absorption |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
DE102008019339A1 (de) * | 2008-04-16 | 2009-10-22 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum |
SI2354191T1 (sl) * | 2010-01-25 | 2013-08-30 | Omya Development Ag | Uporaba 2-((1-metilpropil)amino)etanola kot dodatka vodni suspenziji materialov, ki vsebujejo kalcijev karbonat |
SI2392622T1 (sl) * | 2010-06-07 | 2013-07-31 | Omya Development Ag | Uporaba 2-aminoetanola kot dodatka v vodnih suspenzijah materialov, ki vsebujejo kalcijev karbonat |
US10568957B2 (en) * | 2012-04-23 | 2020-02-25 | Bharat Biotech International Ltd. | Rotavirus vaccine compositions and process for preparing the same |
RU2715906C2 (ru) | 2015-05-29 | 2020-03-04 | Джонсон энд Джонсон Консьюмер Инк. | Применение органического экстракта цитрусовых с высокой противомикробной активностью и ксилита в качестве системы консервантов в жидкостях, эмульсиях, суспензиях, кремах и антацидах |
RU2714879C2 (ru) | 2015-05-29 | 2020-02-20 | Джонсон энд Джонсон Консьюмер Инк. | Применение органического экстракта цитрусовых с высокой противомикробной активностью в качестве системы консервантов в жидкостях, эмульсиях, суспензиях, кремах и антацидах |
KR101841355B1 (ko) * | 2016-09-02 | 2018-03-22 | 영남대학교 산학협력단 | D-싸이클로세린의 약제학적 제형 및 이의 제조방법 |
CN108721213A (zh) * | 2017-04-13 | 2018-11-02 | 辽宁大熊制药有限公司 | 铝镁混悬液及其制备方法 |
KR101926853B1 (ko) * | 2018-04-13 | 2018-12-07 | 보령제약 주식회사 | 약학적 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9406629A (pt) * | 1993-05-26 | 1996-02-06 | Procter & Gamble | Composições antiacidas liquidas |
US5496567A (en) * | 1993-08-26 | 1996-03-05 | Mclean; Linsey | Composition having buffering and nutritional properties |
CA2168959A1 (en) * | 1993-10-13 | 1995-04-20 | Constantine Georgiades | Antacid pharmaceutical composition |
US5455050A (en) * | 1993-11-12 | 1995-10-03 | Mcneil-Ppc, Inc. | Aqueous antacids with calcium carbonate and magnesium salt |
US5498426A (en) * | 1994-10-03 | 1996-03-12 | The Procter & Gamble Company | Liquid antacid compositions |
DE19529862A1 (de) * | 1995-08-14 | 1997-02-20 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
US5914135A (en) * | 1997-04-16 | 1999-06-22 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
-
1997
- 1997-04-16 US US08/838,239 patent/US5914135A/en not_active Expired - Lifetime
-
1998
- 1998-04-09 NZ NZ330173A patent/NZ330173A/en unknown
- 1998-04-09 AU AU61902/98A patent/AU727008B2/en not_active Ceased
- 1998-04-14 BR BRPI9801044-1A patent/BR9801044B1/pt not_active IP Right Cessation
- 1998-04-14 JP JP10117890A patent/JPH10316577A/ja active Pending
- 1998-04-15 AT AT98302895T patent/ATE232105T1/de not_active IP Right Cessation
- 1998-04-15 CZ CZ19981134A patent/CZ292399B6/cs not_active IP Right Cessation
- 1998-04-15 ZA ZA9803167A patent/ZA983167B/xx unknown
- 1998-04-15 RU RU98107577/14A patent/RU2193889C2/ru active
- 1998-04-15 DK DK98302895T patent/DK0872241T3/da active
- 1998-04-15 HU HU9800876A patent/HU224195B1/hu not_active IP Right Cessation
- 1998-04-15 EP EP98302895A patent/EP0872241B1/en not_active Expired - Lifetime
- 1998-04-15 ES ES98302895T patent/ES2191254T3/es not_active Expired - Lifetime
- 1998-04-15 AR ARP980101735A patent/AR012438A1/es active IP Right Grant
- 1998-04-15 DE DE69811137T patent/DE69811137T2/de not_active Expired - Fee Related
- 1998-04-16 PL PL98325821A patent/PL189771B1/pl not_active IP Right Cessation
- 1998-04-16 KR KR1019980013552A patent/KR100588245B1/ko not_active IP Right Cessation
- 1998-04-16 CN CNB981148255A patent/CN1174754C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69811137T2 (de) | 2003-11-27 |
HU224195B1 (hu) | 2005-06-28 |
EP0872241B1 (en) | 2003-02-05 |
ZA983167B (en) | 1999-10-15 |
BR9801044B1 (pt) | 2009-05-05 |
EP0872241A3 (en) | 1999-09-22 |
HU9800876D0 (en) | 1998-05-28 |
KR19980081452A (ko) | 1998-11-25 |
RU2193889C2 (ru) | 2002-12-10 |
EP0872241A2 (en) | 1998-10-21 |
US5914135A (en) | 1999-06-22 |
ES2191254T3 (es) | 2003-09-01 |
ATE232105T1 (de) | 2003-02-15 |
HUP9800876A3 (en) | 2000-07-28 |
CZ292399B6 (cs) | 2003-09-17 |
CZ113498A3 (cs) | 1998-11-11 |
KR100588245B1 (ko) | 2006-09-20 |
AU6190298A (en) | 1998-10-22 |
PL325821A1 (en) | 1998-10-26 |
NZ330173A (en) | 1998-11-25 |
AU727008B2 (en) | 2000-11-30 |
BR9801044A (pt) | 2000-01-11 |
HUP9800876A2 (hu) | 1999-05-28 |
PL189771B1 (pl) | 2005-09-30 |
DE69811137D1 (de) | 2003-03-13 |
JPH10316577A (ja) | 1998-12-02 |
CN1203079A (zh) | 1998-12-30 |
CN1174754C (zh) | 2004-11-10 |
DK0872241T3 (da) | 2003-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012438A1 (es) | Preparacion liquida antiacida libre de conservadores que es de ph estable, durante su vida de almacenamiento | |
ES2527760T3 (es) | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos | |
EP1820516A3 (en) | Novel albumin-free factor VIII formulations | |
ATE494902T1 (de) | Ein huhn gnrh-ii analog zur verwendung in der reduktion des tumorzellwachstums | |
BR0101332A (pt) | Formulação oftálmica tópica na forma de uma solução aquosa, e, uso de uma ciclosporina em associação com ácido hialurÈnico ou um de seus sais e com polisorbato 80 | |
AR047949A1 (es) | Preparacion farmaceutica que comprende un anticuerpo contra el receptor de factor de crecimiento endotelial | |
PE20110236A1 (es) | Proteccion y mejoramiento de celulas, tejidos y organos que responden a la eritropoyetina | |
GB2414680A (en) | Low profile spinal fixation system | |
CO5700797A2 (es) | Composicion de farmaco conjugado | |
EP1629849A3 (en) | Pharmaceutical compositions comprising exendins and agonists thereof | |
BR0311877A (pt) | Preparações ácidas de insulina com estabilidade aperfeiçoada | |
BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
BRPI0111639B8 (pt) | uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica. | |
ES2111547T3 (es) | Comprimido de liberacion prolongada. | |
MX9710206A (es) | Composicion farmaceutica de amiodarone para administracion parenteral. | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
YU46503A (sh) | Farmaceutski oblik dronedarona za parenteralnu upotrebu | |
MXPA04003540A (es) | Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo. | |
GB9905663D0 (en) | Iodine preparation composition | |
MY136546A (en) | A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component | |
HK1049789A1 (en) | Solubilized pharmaceutical composition for parenteral administration | |
MY123805A (en) | Stabilized pharmaceutical composition based on quinupristine and dalfopristine and their preparation. | |
ES2156763A1 (es) | Formulacion estables de solucion de apomorfina. | |
BR0010499A (pt) | Agentes endoparasiticidas | |
CY1116016T1 (el) | Μεθοδος και kit για την εφυγρανση της επιφανειας του οφθαλμου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |